Sign In
NewsRadar

Pantec Biosolutions

Pantec Biosolutions is a drug delivery company specialized in laser micro-poration technology to deliver large molecular weight drugs into the epidermis for systemic or topical uptake. The technology avoids unwanted therapeutic side effects such as drug degradation. Its LEDDT (Laser Easy Drug Delivery Technology) platform enables needle free and painless application of biopharmaceutical drugs, such as IVF hormones, in varying and individualized dosages through partnered patch technology.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Industriering 21
Ruggell 9491
Liechtenstein
+423 377 13 90
+423 377 13 99
http://www.pantec-biosolutions.com
Christof Boehler
+423 377 13 90

Company Facts
Founded:Dec 2005
Founders:
CEO:Christof Boehler
CTO or technical lead:Thomas Bragagna
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Medical devices
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,442
Tech investments
From our Online Data Service
17,073
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 6€9.3MSoftware development
Dec 6€1.5MConsumer applications
Dec 6€3.7MInternet commerce
Dec 5€8.0MNanotechnology
Dec 5€11.0MBiotechnology
Dec 5€11.0MRobotics
Dec 5N/ARobotics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.